文献速递类风湿关节炎

类风湿关节炎中剪接机器受损并与疾病活动相关及受抗TNF治疗调节

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
PubMed 文献 · Ann Rheum Dis · 2021-10-08

该研究在129例类风湿关节炎(RA)患者和29名健康供者外周血白细胞中评估45个剪接机器元件(SME),发现8个SME在全部白细胞亚型中一致异常,可区分RA与健康、ACPA阳性、高疾病活动度(DAS28>5.1)、放射学受累及动脉粥样斑块;抗TNF治疗3和6个月可逆转其表达并伴随炎症减轻。

要点

  • RA白细胞存在8个SME(SNRNP70、SNRNP200、U2AF2、RNU4ATAC、RBM3、RBM17、KHDRBS1、SRSF10)一致异常。
  • 该SME特征可鉴别RA与健康、ACPA阳性、高疾病活动度(DAS28>5.1)、放射学受累及动脉粥样斑块。
  • 抗TNF治疗3和6个月可逆转SME表达并伴随炎症谱降低。

核心结论

  • 首次在RA外周血和滑液白细胞中鉴定出由8个失调SME组成的特征,与疾病病理生理相关,受ACPA调节并被抗TNF治疗逆转。

研究设计与样本

  • 研究纳入129例RA患者和29名健康供者(HD),纯化白细胞亚型,用基于微流控技术的定量PCR阵列(Fluidigm)评估45个选定SME。
  • 评估抗TNF治疗对SME的调节及潜在调控机制,并在K/BxN关节炎小鼠踝关节和RA滑液中验证。

主要发现

  • RA白细胞中多个SME表达改变,其中SNRNP70、SNRNP200、U2AF2、RNU4ATAC、RBM3、RBM17、KHDRBS1和SRSF10在全部白细胞亚型中一致异常。
  • 逻辑回归显示该特征可区分RA与HD、ACPA阳性、高疾病活动度(DAS28>5.1)、放射学受累及动脉粥样斑块。
  • 该特征在RA滑液和K/BxN关节炎小鼠踝关节中亦异常;RNA-seq数据验证并识别高、低SME水平RA患者间不同剪接事件和变体。
  • 抗TNF治疗3和6个月逆转SME表达并伴随炎症谱降低;体外ACPA通过Fc受体(FcR)依赖机制部分调节SME,关键炎性细胞因子进一步改变SME。
  • 诱导SNRNP70或KHDRBS1过表达可逆转淋巴细胞炎症、中性粒细胞NETosis和RA单核细胞黏附,并影响RA滑膜成纤维细胞活性。

关键数值与推荐

  • 高疾病活动度定义为DAS28>5.1。
  • 抗TNF治疗评估时间点为3和6个月。

临床怎么用

  • 八SME特征可能作为RA诊断、疾病活动度、放射学受累及动脉粥样斑块的潜在生物标志物。
  • 抗TNF治疗可逆转SME表达,提示SME或可监测治疗反应。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterise splicing machinery (SM) alterations in leucocytes of patients with rheumatoid arthritis (RA), and to assess its influence on their clinical profile and therapeutic response. METHODS: Leucocyte subtypes from 129 patients with RA and 29 healthy donors (HD) were purified, and 45 selected SM elements (SME) were evaluated by quantitative PCR-array based on microfluidic technology (Fluidigm). Modulation by anti-tumour necrosis factor (TNF) therapy and underlying regulatory mechanisms were assessed. RESULTS: An altered expression of several SME was found in RA leucocytes. Eight elements (SNRNP70, SNRNP200, U2AF2, RNU4ATAC, RBM3, RBM17, KHDRBS1 and SRSF10) were equally altered in all leucocytes subtypes. Logistic regressions revealed that this signature might: discriminate RA and HD, and anti-citrullinated protein antibodies (ACPAs) positivity; classify high-disease activity (disease activity score-28 (DAS28) >5.1); recognise radiological involvement; and identify patients showing atheroma plaques. Furthermore, this signature was altered in RA synovial fluid and ankle joints of K/BxN-arthritic mice. An available RNA-seq data set enabled to validate data and identified distinctive splicing events and splicing variants among patients with RA expressing high and low SME levels. 3 and 6 months anti-TNF therapy reversed their expression in parallel to the reduction of the inflammatory profile. In vitro, ACPAs modulated SME, at least partially, by Fc Receptor (FcR)-dependent mechanisms. Key inflammatory cytokines further altered SME. Lastly, induced SNRNP70-overexpression and KHDRBS1-overexpression reversed inflammation in lymphocytes, NETosis in neutrophils and adhesion in RA monocytes and influenced activity of RA synovial fibroblasts. CONCLUSIONS: Overall, we have characterised for the first time a signature comprising eight dysregulated SME in RA leucocytes from both peripheral blood and synovial fluid, linked to disease pathophysiology, modulated by ACPAs and reversed by anti-TNF therapy.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ibáñez-Costa A, Perez-Sanchez C, Patiño-Trives AM, et al. Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy. Ann Rheum Dis. 2021. PMID: 34625402. doi:10.1136/annrheumdis-2021-220308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。